联合抗凝治疗在心源性脑栓塞中的应用效果  

Effect of Combined Anticoagulant Therapy in Cardiogenic Cerebral Infarction

作　　者：李婷 LI Ting(Shenyang First People's Hospital,Shenyang 110041,China)

机构地区：[1]沈阳市第一人民医院,辽宁沈阳110041

出　　处：《中国医药指南》2020年第27期123-124,共2页Guide of China Medicine

摘　　要：目的分析联合抗凝治疗在心源性脑栓塞中的应用效果。方法选取我院2017年10月至2018年10月收治的116例心源性脑栓塞患者,按随机序列法,分为观察组和对照组,每组58例。对照组行常规治疗,观察组在常规治疗基础上行联合抗凝治疗。对比两组患者治疗有效率、NHISS卒中评分、SF-36生活质量评分、并发症发生率、MAS运动功能评分。结果观察组患者治疗有效率以及治疗后的SF-36生活质量评分、MAS运动功能评分均高于对照组(P<0.05),并发症发生率、NHISS卒中评分低于对照组(P<0.05)。结论联合抗凝治疗在心源性脑栓塞中的应用效果理想,可改善患者病情,也能提升患者生活质量和运动功能,且并发症较少。Objective To analyze the effect of combined anticoagulant therapy in cardiogenic cerebral embolism.Methods One hundred and sixteen patients with cardiogenic cerebral embolism admitted to our hospital from October 2017 to October 2018 were randomly divided into observation group and control group,with 58 cases in each group.The control group received routine treatment,and the observation group received anticoagulation therapy on the basis of conventional treatment.The treatment efficiency,NHISS stroke score,SF-36 quality of life,complication rate,and MAS motor function score were compared between the two groups.Results The effective rate of treatment and the scores of quality of life and motor function of the observation group were higher than those of the control group(P<0.05),and the complication rate and stroke score were lower than those of the control group(P<0.05).Conclusion Combined anticoagulant therapy is effective in cardiogenic cerebral embolism,which can improve the patient's condition,improve the patient's quality of life and motor function,and have fewer complications.

关 键 词：心源性脑栓塞 联合抗凝 运动功能 卒中评分 生活质量评分 

分 类 号：R743[医药卫生—神经病学与精神病学]